OCT 25, 2021 9:59 AM PDT

Illuminating Blips in Blood Flow to the Brain

WRITTEN BY: Tara Fernandez


 

Just like an athlete needs to consume a huge number of calories to support their rigorous training regimes, neurons in the brain need significant amounts of oxygen and glucose to function properly. To fulfill this demand, around three cups of blood flow to the brain every minute, supplying neural tissue with the nutrients it needs and carting away toxins. This blood supply is termed the cerebral blood flow or CBF. 

Neuroscientists have connected the dots between alterations or disruptions in CBF and the onset of neurological disorders, including seizures, Alzheimer’s disease, migraines, and stroke. These links suggest that measuring and tracking the CBF may represent a viable diagnostic tool. For this purpose, physicians have been relying on a non-invasive diagnostic technique known as speckle imaging. 

Here, a series of short-exposure shots are taken of the patient’s head to gain insights into physiological changes occurring beneath the skull. However, speckle imaging data doesn’t paint a complete picture—the direction and speed of CBF are missing, making it impossible for neurologists to pick up and monitor changes in blood flow to the brain.

Work by a team of Korean researchers is paving the way for next-gen CBF imaging technology. The scientists unveiled “optical speckle image velocimetry” or OSIV in a study published in the journal Optica. This new technology allows for the quantitative analysis of CBF, providing unprecedented data on the speed and direction of blood flow to the brain in real-time. 

According to the study, OSIV is powered by particle image velocimetry to measure blood flow speeds of up to 7 mm/s. To validate OSIV’s full potential, the researchers used an animal model of stroke. With this innovative new technique, they could access precise, quantitative blood flow measurements before and after stroke without the need for a tracer or high-speed camera. 

Lead researcher Euiheon Chung is optimistic that such technology will soon find its way to clinical diagnostic facilities. “Our study can be used to understand the vascular mechanisms and test new drugs for treating vascular-related diseases such as stroke, AD, and diabetes,” said Chung





 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 10, 2021
Clinical & Molecular DX
New CRISPR Device Diagnoses COVID in an Hour, Detects Variants
AUG 10, 2021
New CRISPR Device Diagnoses COVID in an Hour, Detects Variants
A team of engineers from MIT and Harvard University has developed a COVID diagnostic device with a tiny footprint but hu ...
AUG 12, 2021
Clinical & Molecular DX
Computers Pick Up the 'Sound' of Thyroid Cancer
AUG 12, 2021
Computers Pick Up the 'Sound' of Thyroid Cancer
Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic ...
SEP 30, 2021
Clinical & Molecular DX
How Babies Look at Objects Linked to Future Autism Diagnoses
SEP 30, 2021
How Babies Look at Objects Linked to Future Autism Diagnoses
At nine months old, most babies have started moving around independently and are curiously exploring the exciting new wo ...
NOV 02, 2021
Coronavirus
COVID vaccines have saved 245,000 lives and counting
NOV 02, 2021
COVID vaccines have saved 245,000 lives and counting
What began in December 31, 2019 as a cluster of cases of pneumonia with an unknown etiology, quickly spread throughout t ...
NOV 11, 2021
Clinical & Molecular DX
Cancer Pathologist Burnout? AI to the Rescue.
NOV 11, 2021
Cancer Pathologist Burnout? AI to the Rescue.
Diagnosing cancer is hard work. The challenging demands of their caseloads see diagnostic pathologists in many clinical ...
NOV 15, 2021
Health & Medicine
Alpha-synuclein as a Biomarker for Parkinson's Disease
NOV 15, 2021
Alpha-synuclein as a Biomarker for Parkinson's Disease
Parkinson’s disease (PD) is a widespread neurogenerative disorder that can significantly impact a person’s q ...
Loading Comments...